Comparing Transgender and Cisgender Experiences of Being Taken Advantage of Sexually While Under the Influence of Alcohol and/or Other Drugs.


Journal

Journal of sex research
ISSN: 1559-8519
Titre abrégé: J Sex Res
Pays: United States
ID NLM: 0062647

Informations de publication

Date de publication:
Historique:
pubmed: 29 4 2021
medline: 25 11 2021
entrez: 28 4 2021
Statut: ppublish

Résumé

A small body of literature suggests that transgender people are more frequently exposed to sexual violence while they are under the influence of alcohol than cisgender counterparts. The goal of this study was to report any differences between transgender (n = 1,136) and cisgender (n = 74,277) respondents to the Global Drug Survey on their experiences of being taken advantage of sexually while under the influence of alcohol and/or other drugs. We found that transgender people were more likely than cisgender people to have experienced being taken advantage of in the last year (9.3% vs 4.2%) and more than 12 months preceding the survey (24.9% vs 14.3%). Non-binary participants were more likely than binary transgender participants (27.7% vs 17.8%) to report being taken advantage of sexually more than a year preceding the survey. Similarly, trans respondents assigned female at birth were more likely than trans respondents assigned male at birth to report this (30.0% vs 19.7%). Nonspecialist services for survivors of sexual violence should be adequately prepared for and accommodating toward transgender clients. Future research should explore their unique needs. Moreover, clinicians who assess transgender people should remain mindful of their increased likelihood of being taken advantage of sexually while under the influence of alcohol and other drugs and consider trauma-informed interventions.

Identifiants

pubmed: 33908334
doi: 10.1080/00224499.2021.1912692
doi:

Substances chimiques

Pharmaceutical Preparations 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1112-1117

Auteurs

Dean Connolly (D)

Addictions Sciences Building, Institute of Psychiatry, Psychology and Neuroscience, King's College London.
Whipps Cross University Hospital, Barts Health NHS Trust.

Alexandra Aldridge (A)

School of Law, Royal Holloway, University of London.

Emma Davies (E)

Faculty of Health and Life Sciences, Oxford Brookes University.

Larissa J Maier (LJ)

Department of Clinical Pharmacy, University of California.
Early Postdoc Mobility Grantee (P2ZHP1_174812), Swiss National Science Foundation.

Jason Ferris (J)

Centre for Health Services Research, Faculty of Medicine, The University of Queensland.

Gail Gilchrist (G)

Addictions Sciences Building, Institute of Psychiatry, Psychology and Neuroscience, King's College London.

Adam Winstock (A)

Institute of Epidemiology & Health Care, University College London.
Global Drug Survey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH